Is America still a place where big ideas can move policymakers to slash red tape in drug development to save lives, drive innovation and spur economic growth?It certainly appears so. The Obama administration, industry, the Food and Drug Administration and patients’ groups have all come together in recent months to highlight the need for regulatory reforms to help patients gain faster access to safer and more innovative medicines. Read More

Last week at a meeting of the American Society of Clinical Oncology, ASCO President George Sledge painted a hopeful, but also challenging, picture about new genomic technologies for fighting cancer. These technologies can unravel the genetic mechanisms driving the disease and point the way to new strategies to overcome cancer-drug resistance. Read More

On Dec. 16, the Food and Drug Administration made a decision that could cause thousands of breast cancer patients to lose their last hope. That day, officials voted to revoke approval for Avastin for the treatment of late-stage breast cancer. This move is a disgrace. Read More